Publication stageIn Press Journal Pre-Proof
Funding support: This work was not support by any grant funding.
Previous Presentations: This work has not been previously presented.
Conflicts of Interest: Sally Rafie is a Clinical Advisory Board member for Afaxys Inc and speaker for TherapeuticsMD.
Author Contributions (using CRediT taxonomy)
CM: Conceptualization, Writing – original draft & preparation, review & editing
VV: Conceptualization, Writing – original draft & preparation, review & editing
SR: Conceptualization, Writing – original draft & preparation, review & editing
What Was Already Known
• Nineteen million women live in contraception deserts.
• Pharmacist contraception services are growing in prevalence as 18 states and jurisdictions now grant pharmacists the authority to prescribe hormonal contraceptives.
• Structural barriers including narrow policies that limit scope of practice and prevent insurance coverage of pharmacist services have led to limited uptake of contraception prescribing by pharmacists.
What This Commentary Adds
• Pharmacists have an opportunity to elevate their practice and expand their services to ensure access to contraception and related reproductive health care within their communities.
• Pharmacists can elevate their practice by integrating reproductive justice principles to facilitate patient autonomy and access.
• Pharmacists can expand their services by providing related sexual and reproductive health services to facilitate comprehensive contraception services.